Xenetic Biosciences, Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update Aug 13, 2021
Xenetic Biosciences, Inc. Announces Closing of $12.5 Million Private Placement Priced at a Premium to Market Jul 28, 2021
Xenetic Biosciences, Inc. Announces $12.5 Million Private Placement Priced at a Premium to Market Jul 26, 2021
Xenetic Biosciences, Inc. to Present at the H.C. Wainwright Global Life Sciences Conference Mar 3, 2021
Xenetic Biosciences, Inc. Announces Partner's Filing of Registration Dossier in Russia for Epolong Product Candidate That Utilizes Xenetic's PolyXen(R) Platform Technology Feb 16, 2021